SCHEMBL19982767

SCHEMBL19982767

C=Nn1ccnc(N2CCCC(C(=O)NCCO)C2)/c1=N/CNc1cc(OC)cc(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
ALDH1A1 P00352 2/20 0.43
ALK Q9UM73 4/20 0.42
IGF1R P08069 2/20 0.42
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
POLB P06746 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16408702 0.75 ALK (0.52) HPGDLMNAALDH1A1ALKIGF1R
SCHEMBL15210468 0.62 LMNA (0.48) HPGDLMNAALDH1A1ALKIGF1R
SCHEMBL16394514 0.61 HPGD (0.48) HPGDLMNAALDH1A1ALKIGF1R
SCHEMBL14316007 0.59 KDM4E (0.57) HPGDLMNAALDH1A1KDM4ENPC1
SCHEMBL15022155 0.59 ALK (1.00) ALKIGF1R
SCHEMBL13162836 0.57 ITGB3 (0.51) HPGDLMNAALDH1A1KDM4ENPC1
SCHEMBL23857926 0.56 ALDH1A1 (0.63) LMNAALDH1A1KDM4ENPC1RAB9A
Oxalic Acid SCHEMBL9348857 0.55 ITGB3 (0.52) HPGDLMNAALDH1A1NPC1RAB9A
SCHEMBL14788156 0.55 KMT2A (0.47) ALDH1A1KDM4ENPC1RAB9AKMT2A
SCHEMBL30919618 0.54 KDM4E (0.46) HPGDLMNAKDM4EPOLBGPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2817310-B1 8-SUBSTITUTED 2-AMINO-[1,2,4]TRIAZOLO[1,5-A]PYRAZINES AS SYK TRYROSINE KINASE INHIBITORS AND GCN2 SERIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2018-03-21 EP disclosed